MindMed Announces New Employee Inducement Grants
NEW YORK — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to four
(Financial Post, 2025-12-01T21:07:39Z)